Products Categories
CAS No.: | 11103-86-9 |
---|---|
Name: | potassium hydroxyoctaoxodizincatedichromate(1-) |
Molecular Structure: | |
Formula: | Cr2HO9Zn2•K |
Molecular Weight: | 418.85 |
Synonyms: | Zinc Yellow;CHROMIC ACID, POTASSIUM ZINC SALT (2:2:1);ZINC CHROME;POTASSIUM ZINC CHROMATE; |
EINECS: | 234-329-8 |
Density: | g/cm3 |
Boiling Point: | °Cat760mmHg |
Flash Point: | °C |
Solubility: | 500mg/L at 20℃ |
Hazard Symbols: | Toxic by ingestion. |
Safety: | Confirmed carcinogen. Mutation data reported. When heated to decomposition it emits toxic fumes of ZnO and K2O. Used as a corrosion inhibiting pigment and in steel priming. See also CHROMIUM COMPOUNDS and ZINC COMPOUNDS. |
PSA: | 0.00000 |
LogP: | 0.00000 |
What can I do for you?
Get Best Price
IUPAC Name: Potassium dizinc dioxido(dioxo)chromium hydroxide
Synonyms: Chromium, diolatodioxo-, hydroxide (2:1), potassium dizinc salt ; Chromium, diolatodioxo-, hydroxide, potassium zinc salt (2:1:2) ; Potassium zinc hydroxide dioxido(dioxo)chromium (1:2:1:2)
Product Categories: Inorganics
CAS NO: 11103-86-9
Molecular Formula of Potassium zinc chromate hydroxide (CAS NO.11103-86-9) : HCr2KO9Zn2
Molecular Weight of Potassium zinc chromate hydroxide (CAS NO.11103-86-9) : 418.911
Molecular Structure of Potassium zinc chromate hydroxide (CAS NO.11103-86-9) :
1. | mmo-sat 33 µg/plate | EMMUEG Environmental and Molecular Mutagenesis. 11 (Suppl 12)(1988),1. |
IARC Cancer Review: Group 1 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 49 ,1990,p. 49.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 49 ,1990,p. 49.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 49 ,1990,p. 49.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 23 ,1980,p. 205.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . Chromium and its compounds, as well as zinc and its compounds, are on the Community Right-To-Know List. Reported in EPA TSCA Inventory.
Confirmed carcinogen. Mutation data reported. When heated to decomposition it emits toxic fumes of ZnO and K2O. Used as a corrosion inhibiting pigment and in steel priming. See also CHROMIUM COMPOUNDS and ZINC COMPOUNDS.
RIDADR 3288
HazardClass 6.1(a)
PackingGroup II
OSHA PEL: CL 0.1 mg(CrO3)/m3
ACGIH TLV: TWA 0.01 mg(Cr)/M3; Confirmed Human Carcinogen
DFG MAK: Human Carcinogen
NIOSH REL: (Chromium (VI)) TWA 0.001 mg(Cr(VI))/m3